A cikin zamani da magani da magunguna, wasu binciken ya faru a kai a kai. Ana yin kome don rage sauƙin maganin wasu cututtuka. Ɗaya daga cikin binciken da ya fi samuwa shine ƙwayoyin cuta guda daya. Mafi yawan cututtukan da jiki ya samar su ne polyclonal. A taƙaice, an tsara su don yin yaki tare da antigens daban-daban, wanda hakan ya rage tasirin magani. Magungunan monoclonal suna aiki da gangan, suna ba da damar karɓar sakamako mai kyau mafi kyau.
Maganar magani tare da kwayoyin cutar guda daya
Har zuwa yau, ana amfani da kwayoyin cutar guda daya don ƙayyadewa ko ake kira ci gaba. Kamar yadda gwaje-gwaje suka nuna, wannan hanyar yana nuna kyakkyawan sakamako na magani.
Magunguna na monoclonal sune kwayoyin cutar da suka samo asali ne daga guda guda clone. Wato, kowannensu suna da sel daya kawai. Ana amfani da kwayoyin monoclonal don:
- colitis ;
- rheumatoid arthritis;
- psoriasis;
- Multi sclerosis .
Suna taimakawa wajen yakin ko da magungunan ilimin halittu.
Ka'idar aiwatar da kwayar cutar guda daya shine mai sauƙi: sun gane wasu antigens kuma sun haɗa su. Na gode da wannan, tsarin gaggawa yana lura da matsala kuma ya fara yakar shi. A gaskiya, magunguna guda daya suna bada izinin jiki don kawar da antigens da kansa. Wani babban amfani da MCA shi ne kawai suna canza kwayoyin halitta ba tare da haddasa cutar ba.
Monoclonal antibodies a kan oncology
Ga marasa lafiya da yawa da ilimin ilimin halitta, kwayoyi da suka haɗa da kwayoyin cutar guda daya sun zama kawai fata don dawowa zuwa al'ada. Babban ɓangaren marasa lafiya da mummunan ciwon sukari da kuma mummunar bala'i bayan dajin magani ya ji wani taimako mai sauƙi.
Abũbuwan amfãni daga ICA bayyane yake:
- Yin amfani da kwayoyin cutar ciwon daji, kwayoyin halitta guda daya ba kawai ya sa su zama bayyane ba, amma kuma ya raunana. Kuma tare da kwayoyin halitta marasa lafiya na jiki, jiki yana da sauƙi don yakin.
- Magunguna guda daya da suka gano manufar su suna taimakawa wajen hana masu karbar ciwon tumo. Na gode da wannan maganin ilimin ilimin kimiyyar ilimin kimiyyar ilimin kimiyyar ilimin kimiyyar ilimin kimiyyar ilimin halittu yana da sauƙin sauƙaƙe
- Ana samo asibitoci a cikin dakin gwaje-gwaje, inda aka haɗa su da ƙananan ƙwayoyin rediyo. Samun waɗannan barbashi ta jiki, MCA ya ba su daidai da tsari, inda suke aiki.
Ana iya kwatanta maganin ciwon daji tare da kwayar cutar guda daya tare da radiotherapy. Amma ba kamar wannan batu ba, ICA ta yi aiki sosai. Sakamakonsu ya sa ya yiwu a yi amfani da ƙananan ƙananan ƙwayoyin rediyo.
Magunguna da ke dauke da kwayoyin halitta guda daya
Kodayake gaskiyar cewa ICA ba ta kirkira ba ne tun lokacin da suka wuce, yawancin shirye-shiryen da suke dauke da su sun kasance da ban sha'awa sosai. Sabbin magunguna sun bayyana a kai a kai.
Mafi shahararren kwayoyin da ake amfani da shi a yau don psoriasis, sclerosis da yawa, ciwon daji, cututtuka na rheumatoid, colitis kama da wannan:
- Alemtuzumab;
- Alamar shiga;
- Daclusimab;
- Okrelizumab;
- Ustenkin;
- Basiliximab;
- Ofatumumab;
- Kayan aiki;
- Clenoliximab;
- Bevacizumab;
- Trastuzumab;
- Adalimumab;
- Enbrel;
- Infliximab da sauransu.
Hakika, kwayoyin cutar guda daya, kamar sauran kwayoyi, na iya haifar da tasiri. Mafi sau da yawa, marasa lafiya bayan amfani da ICA suna korafi game da bayyanar rashin lafiyan halayen: itching, rash. A wasu lokuta mawuyacin hali, jiyya yana tare da tashin zuciya, vomiting, ko ciwon zuciya.